These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15825631)

  • 21. Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
    Daniel H; Bornstein SS;
    Ann Intern Med; 2019 Dec; 171(11):823-824. PubMed ID: 31711103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ineffectiveness of retrospective drug utilization review.
    Hennessy S; Strom BL
    LDI Issue Brief; 2003 Sep; 9(1):1-4. PubMed ID: 14577443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growing pains. Insurers and PbMs want in on 340B savings.
    Lee J
    Mod Healthc; 2012 Mar; 42(11):10. PubMed ID: 22462315
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicare-approved drug discount cards and renal transplant patients: how much can these cards reduce prescription costs?
    Chisholm MA; Marshall J; Smith KE; Garrett CJ; Turner JC
    Clin Transplant; 2005 Jun; 19(3):357-63. PubMed ID: 15877798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacy benefit management contracting: an assessment from a recent public sector procurement experience.
    Bae JP; Justice PG
    J Health Care Finance; 2002; 29(1):49-56. PubMed ID: 12199494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PBMs to the rescue? Pharmacy benefit managers will play a key role in the Medicare drug benefit. What does it mean for the industry, consumers and Uncle Sam?
    Fong T
    Mod Healthc; 2005 Nov; 35(48):26-8, 30. PubMed ID: 16617721
    [No Abstract]   [Full Text] [Related]  

  • 28. Undocumented source of pharmacy benefit manager revenue.
    Siracuse MV; Clark BE; Garis RI
    Am J Health Syst Pharm; 2008 Mar; 65(6):552-7. PubMed ID: 18319501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PBMs raise the curtain.
    Sipkoff M
    Manag Care; 2006 Sep; 15(9):38-40, 43. PubMed ID: 17036937
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of a medication copayment increase in veterans with schizophrenia.
    Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plastic price cuts? Drug discount cards shave but don't slash high bills. And most aren't free.
    Comarow A
    US News World Rep; 2002 Apr; 132(12):74-6. PubMed ID: 11974551
    [No Abstract]   [Full Text] [Related]  

  • 33. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PBMs agree to disclose what they pay for drugs.
    Sipkoff M
    Manag Care; 2007 Nov; 16(11):19-20. PubMed ID: 18092549
    [No Abstract]   [Full Text] [Related]  

  • 36. Out-of-pocket and total costs of fixed-dose combination antihypertensives and their components.
    Rabbani A; Alexander GC
    Am J Hypertens; 2008 May; 21(5):509-13. PubMed ID: 18437141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PBMs' rebate income threatened by lawsuits and move to generics.
    Sipkoff M
    Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.